CHALMERS DEREK T 4
4 · Cara Therapeutics, Inc. · Filed Dec 30, 2020
Insider Transaction Report
Form 4
CHALMERS DEREK T
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2020-12-30$15.30/sh−6,078$92,993→ 936,593 total
Footnotes (2)
- [F1]This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of the RSUs reported on Form 4 filed with the Securities and Exchange Commission on December 29, 2020, and does not represent a discretionary trade by the Reporting Person.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding as described in footnote (1).